You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • A randomised controlled trial of gemcitabine hydrochloride plus S-1 combination therapy versus gemcitabine hydrochloride therapy alone in pancreatic cancer patients aged ≥75 years: a study protocol for an open-label randomised feasibility study

Article metrics

Article menu

Download PDFPDF

XML
Pancreatic cancer
A randomised controlled trial of gemcitabine hydrochloride plus S-1 combination therapy versus gemcitabine hydrochloride therapy alone in pancreatic cancer patients aged ≥75 years: a study protocol for an open-label randomised feasibility study

 

Online download statistics by month:

Online download statistics by month: February 2018 to March 2024

AbstractFullPdf
Feb 201893757
Mar 20181271297
Apr 201891917
May 201883834
Jun 201885852
Jul 201893927
Aug 201867671
Sep 201821213
Oct 201810105
Nov 201815159
Dec 201817172
Jan 201919188
Feb 201913125
Mar 201918182
Apr 201918181
May 201919154
Jun 201926230
Jul 201919173
Aug 201914142
Sep 201911124
Oct 201910112
Nov 2019982
Dec 2019161614
Jan 202017151
Feb 202011104
Mar 202024232
Apr 202011114
May 2020986
Jun 2020784
Jul 202016184
Aug 2020560
Sep 20209100
Oct 2020783
Nov 2020785
Dec 202012103
Jan 202113143
Feb 202111120
Mar 202111104
Apr 2021663
May 2021650
Jun 202114141
Jul 2021996
Aug 2021334
Sep 2021983
Oct 2021662
Nov 2021987
Dec 2021862
Jan 2022660
Feb 2022336
Mar 2022879
Apr 2022991
May 2022660
Jun 2022994
Jul 2022870
Aug 202211113
Sep 2022999
Oct 2022541
Nov 2022885
Dec 202216152
Jan 2023781
Feb 2023552
Mar 2023544
Apr 2023664
May 202349517
Jun 202312112
Jul 20237712
Aug 2023228
Sep 2023557
Oct 202312116
Nov 202313137
Dec 2023994
Jan 2024444
Feb 202411110
Mar 202416158
Total13951359288